Tsourapas Panagiotis
COO, CD, EMEA, APac, Skin at CL
- Sold, on record
- $37.4M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Nov 4, 2026
- Form 144 notices
- 13
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CLCOLGATE PALMOLIVE COCOO, CD, EMEA, APac, Skin
Sales by reason
0
Routine
2
Plan not stated
1
No plan
18
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Nov 4, 2026Unusual
Sold 68.6% of their holdings
$2M19,938 shares at $98.74
- Aug 24, 2026No plan
Sold 13.4% of their holdings
$921k10,000 shares at $92.05
- Aug 24, 2026Notice
Filed a notice to sell 10,000 shares
$920k10,000 shares
- Feb 12, 2026Unusual
Sold 82.8% of their holdings
$4.8M50,000 shares at $95.57
- Feb 12, 2026Notice
Filed a notice to sell 15,000 shares
$1.5M15,000 shares
- Feb 11, 2026Notice
Filed a notice to sell 35,000 shares
$3.3M35,000 shares
- Nov 4, 2024Unusual
Sold 28.9% of their holdings
$1.9M20,032 shares at $93.30
- Nov 4, 2024Notice
Filed a notice to sell 20,032 shares
$1.9M20,032 shares
- Aug 8, 2024Unusual
Sold 74.2% of their holdings
$1.5M14,794 shares at $102.94
- Aug 8, 2024Notice
Filed a notice to sell 14,794 shares
$1.5M14,794 shares
10 of 34
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Nov 6, 2026 | CL | COO, CD, EMEA, APac, Skin | Sold | 19,938 | $98.74 | $2M | 9,111 | SEC |
| Nov 4, 2026 | Nov 6, 2026 | CL | COO, CD, EMEA, APac, Skin | Exercised or settledStock Option (Right to Buy) | 19,938 | 0 | SEC | ||
| Nov 4, 2026 | Nov 6, 2026 | CL | COO, CD, EMEA, APac, Skin | Exercised options | 19,938 | $76.41 | $1.5M | 29,049 | SEC |
| Sep 16, 2026 | Sep 18, 2026 | CL | COO, CD, EMEA, APac, Skin | AwardedStock Option (Right to Buy) | 31,814 | 31,814 | SEC | ||
| Sep 16, 2026 | Sep 18, 2026 | CL | COO, CD, EMEA, APac, Skin | Awarded | 4,597 | 11,447 | SEC | ||
| Sep 13, 2026 | Sep 15, 2026 | CL | COO, CD, EMEA, APac, Skin | Withheld for tax | 2,224 | $86.80 | $193k | 6,850 | SEC |
| Aug 24, 2026 | Aug 26, 2026 | CL | COO, CD, EMEA, APac, Skin | Sold | 10,000 | $92.05 | $921k | 64,901 | SEC |
| Feb 23, 2026 | Feb 25, 2026 | CL | COO, Eur., APac, Afr Eur, Skin | Withheld for tax | 13,081 | $97.10 | $1.3M | 21,629 | SEC |
| Feb 23, 2026 | Feb 25, 2026 | CL | COO, Eur., APac, Afr Eur, Skin | Awarded | 25,742 | 34,710 | SEC | ||
| Feb 12, 2026 | Feb 13, 2026 | CL | COO, Eur., APac, Afr Eur, Skin | Sold | 50,000 | $95.57 | $4.8M | 10,415 | SEC |
| Feb 12, 2026 | Feb 13, 2026 | CL | COO, Eur., APac, Afr Eur, Skin | Exercised or settledStock Option (Right to Buy) | 50,000 | 19,938 | SEC | ||
| Feb 12, 2026 | Feb 13, 2026 | CL | COO, Eur., APac, Afr Eur, Skin | Exercised options | 50,000 | $76.41 | $3.8M | 25,415 | SEC |
| Dec 3, 2025 | Dec 5, 2025 | CL | COO, Eur., APac, Afr Eur, Skin | Withheld for tax | 221 | $78.20 | $17k | 10,415 | SEC |
| Sep 13, 2025 | Sep 16, 2025 | CL | COO, Eur., APac, Afr Eur, Skin | Withheld for tax | 1,421 | $83.28 | $118k | 10,575 | SEC |
| Sep 11, 2025 | Sep 12, 2025 | CL | COO, Eur., APac, Afr Eur, Skin | AwardedStock Option (Right to Buy) | 32,949 | 32,949 | SEC | ||
| Sep 11, 2025 | Sep 12, 2025 | CL | COO, Eur., APac, Afr Eur, Skin | Awarded | 4,759 | 11,996 | SEC | ||
| Feb 13, 2025 | Feb 18, 2025 | CL | Grp Pres, Eur& Developing Mkts | Withheld for tax | 7,827 | $87.75 | $687k | 17,885 | SEC |
| Feb 13, 2025 | Feb 18, 2025 | CL | Grp Pres, Eur& Developing Mkts | Awarded | 18,601 | 25,712 | SEC | ||
| Dec 3, 2024 | Dec 5, 2024 | CL | Grp Pres, Eur& Developing Mkts | Withheld for tax | 168 | $94.61 | $16k | 7,111 | SEC |
| Nov 4, 2024 | Nov 5, 2024 | CL | Grp Pres, Eur& Developing Mkts | Sold | 20,032 | $93.30 | $1.9M | 49,172 | SEC |
| Sep 13, 2024 | Sep 16, 2024 | CL | Grp Pres, Eur& Developing Mkts | Withheld for tax | 762 | $105.73 | $81k | 8,039 | SEC |
| Sep 12, 2024 | Sep 16, 2024 | CL | Grp Pres, Eur& Developing Mkts | AwardedStock Option (Right to Buy) | 25,563 | 25,563 | SEC | ||
| Sep 12, 2024 | Sep 16, 2024 | CL | Grp Pres, Eur& Developing Mkts | Awarded | 3,630 | 8,801 | SEC | ||
| Aug 8, 2024 | Aug 12, 2024 | CL | Grp Pres, Eur& Developing Mkts | Sold | 14,794 | $102.94 | $1.5M | 5,146 | SEC |
| Aug 8, 2024 | Aug 12, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised or settledStock Option (Right to Buy) | 14,794 | 0 | SEC | ||
| Aug 8, 2024 | Aug 12, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised options | 14,794 | $72.29 | $1.1M | 19,940 | SEC |
| Jul 31, 2024 | Aug 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Sold | 40,000 | $99.47 | $4M | 5,146 | SEC |
| Jul 31, 2024 | Aug 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised or settledStock Option (Right to Buy) | 40,000 | 14,794 | SEC | ||
| Jul 31, 2024 | Aug 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised options | 40,000 | $72.29 | $2.9M | 45,146 | SEC |
| May 9, 2024 | May 10, 2024 | CL | Grp Pres, Eur& Developing Mkts | Sold | 12,000 | $94.15 | $1.1M | 5,118 | SEC |
| May 9, 2024 | May 10, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised or settledStock Option (Right to Buy) | 12,000 | 54,794 | SEC | ||
| May 9, 2024 | May 10, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised options | 12,000 | $72.29 | $867k | 17,118 | SEC |
| Feb 18, 2024 | Feb 20, 2024 | CL | Grp Pres, Eur& Developing Mkts | Withheld for tax | 8,164 | $83.53 | $682k | 15,041 | SEC |
| Feb 15, 2024 | Feb 20, 2024 | CL | Grp Pres, Eur& Developing Mkts | Awarded | 11,010 | 23,205 | SEC | ||
| Feb 5, 2024 | Feb 7, 2024 | CL | Grp Pres, Eur& Developing Mkts | Plan transaction | 836 | $84.09 | $70k | 0 | SEC |
| Jan 31, 2024 | Feb 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Sold | 30,433 | $84.41 | $2.6M | 12,126 | SEC |
| Jan 31, 2024 | Feb 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised or settledStock Option (Right to Buy) | 30,433 | 0 | SEC | ||
| Jan 31, 2024 | Feb 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Exercised options | 30,433 | $68.16 | $2.1M | 42,559 | SEC |
| Dec 6, 2023 | Dec 8, 2023 | CL | Grp Pres, Eur& Developing Mkts | Withheld for tax | 245 | $77.47 | $19k | 12,126 | SEC |
| Nov 28, 2023 | Nov 30, 2023 | CL | Grp Pres, Eur& Developing Mkts | Sold | 15,000 | $77.83 | $1.2M | 12,371 | SEC |
| Nov 28, 2023 | Nov 30, 2023 | CL | Grp Pres, Eur& Developing Mkts | Exercised or settledStock Option (Right to Buy) | 15,000 | 30,433 | SEC | ||
| Nov 28, 2023 | Nov 30, 2023 | CL | Grp Pres, Eur& Developing Mkts | Exercised options | 15,000 | $68.16 | $1M | 27,371 | SEC |
| Nov 10, 2023 | Nov 14, 2023 | CL | Grp Pres, Eur& Developing Mkts | Sold | 20,000 | $75.36 | $1.5M | 12,292 | SEC |
| Nov 10, 2023 | Nov 14, 2023 | CL | Grp Pres, Eur& Developing Mkts | Exercised or settledStock Option (Right to Buy) | 20,000 | 45,433 | SEC | ||
| Nov 10, 2023 | Nov 14, 2023 | CL | Grp Pres, Eur& Developing Mkts | Exercised options | 20,000 | $68.16 | $1.4M | 32,292 | SEC |
| Sep 13, 2023 | Sep 15, 2023 | CL | Grp Pres, Eur& Developing Mkts | AwardedStock Option (Right to Buy) | 38,886 | 38,886 | SEC | ||
| Sep 13, 2023 | Sep 15, 2023 | CL | Grp Pres, Eur& Developing Mkts | Awarded | 5,301 | 12,292 | SEC | ||
| May 10, 2023 | May 12, 2023 | CL | Grp Pres, Eur& Developing Mkts | Sold | 16,102 | $81.07 | $1.3M | 822 | SEC |
| May 10, 2023 | May 12, 2023 | CL | Grp Pres, Eur& Developing Mkts | Exercised or settledStock Option (Right to Buy) | 13,698 | 0 | SEC | ||
| May 10, 2023 | May 12, 2023 | CL | Grp Pres, Eur& Developing Mkts | Exercised options | 13,698 | $73.00 | $1000k | 20,604 | SEC |
Page 1
Sales and notices (34)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Nov 6, 2026 | CL | COO, CD, EMEA, APac, Skin | Form 4 sale | 19,938 | $2M | 68.6% | Unusual | SEC |
| Aug 24, 2026 | Aug 26, 2026 | CL | COO, CD, EMEA, APac, Skin | Form 4 sale | 10,000 | $921k | 13.4% | No plan | SEC |
| Aug 24, 2026 | Aug 24, 2026 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 10,000 | $920k | Notice | SEC | |
| Feb 12, 2026 | Feb 13, 2026 | CL | COO, Eur., APac, Afr Eur, Skin | Form 4 sale | 50,000 | $4.8M | 82.8% | Unusual | SEC |
| Feb 12, 2026 | Feb 12, 2026 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 15,000 | $1.5M | Notice | SEC | |
| Feb 11, 2026 | Feb 11, 2026 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 35,000 | $3.3M | Notice | SEC | |
| Nov 4, 2024 | Nov 5, 2024 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 20,032 | $1.9M | 28.9% | Unusual | SEC |
| Nov 4, 2024 | Nov 4, 2024 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 20,032 | $1.9M | Notice | SEC | |
| Aug 8, 2024 | Aug 12, 2024 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 14,794 | $1.5M | 74.2% | Unusual | SEC |
| Aug 8, 2024 | Aug 8, 2024 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 14,794 | $1.5M | Notice | SEC | |
| Jul 31, 2024 | Aug 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 40,000 | $4M | 88.6% | Unusual | SEC |
| Jul 31, 2024 | Jul 31, 2024 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 40,000 | $4M | Notice | SEC | |
| May 9, 2024 | May 10, 2024 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 12,000 | $1.1M | 70.1% | Unusual | SEC |
| May 9, 2024 | May 9, 2024 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 12,000 | $1.1M | Notice | SEC | |
| Jan 31, 2024 | Feb 2, 2024 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 30,433 | $2.6M | 71.5% | Unusual | SEC |
| Jan 31, 2024 | Jan 31, 2024 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 30,433 | $2.6M | Notice | SEC | |
| Nov 28, 2023 | Nov 30, 2023 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 15,000 | $1.2M | 54.8% | Unusual | SEC |
| Nov 28, 2023 | Nov 28, 2023 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 15,000 | $1.2M | Notice | SEC | |
| Nov 10, 2023 | Nov 14, 2023 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 20,000 | $1.5M | 61.9% | Unusual | SEC |
| Nov 10, 2023 | Nov 13, 2023 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 20,000 | $1.5M | Notice | SEC | |
| May 10, 2023 | May 12, 2023 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 16,102 | $1.3M | 70.0% | Unusual | SEC |
| May 10, 2023 | May 10, 2023 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 13,698 | $1.1M | Notice | SEC | |
| May 4, 2023 | May 5, 2023 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 55,000 | $4.4M | 88.8% | Unusual | SEC |
| May 4, 2023 | May 4, 2023 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 20,000 | $1.6M | Notice | SEC | |
| May 3, 2023 | May 3, 2023 | CL | COO, CD, EMEA, APac, Skin | Form 144 notice | 35,000 | $2.8M | Notice | SEC | |
| Feb 9, 2022 | Feb 11, 2022 | CL | Grp Pres, Eur& Developing Mkts | Form 4 sale | 25,000 | $2M | 78.9% | Unusual | SEC |
| Nov 18, 2020 | Nov 20, 2020 | CL | Grp Pres, LatAm,AsiaPac&AF/Eus | Form 4 sale | 11,714 | $999k | 71.5% | Unusual | SEC |
| Nov 16, 2020 | Nov 18, 2020 | CL | Grp Pres, LatAm,AsiaPac&AF/Eus | Form 4 sale | 15,000 | $1.3M | 76.2% | Unusual | SEC |
| Nov 11, 2020 | Nov 12, 2020 | CL | Grp Pres, LatAm,AsiaPac&AF/Eus | Form 4 sale | 7,500 | $638k | 61.6% | Unusual | SEC |
| Nov 4, 2020 | Nov 6, 2020 | CL | Grp Pres, LatAm,AsiaPac&AF/Eus | Form 4 sale | 20,000 | $1.7M | 81.1% | Unusual | SEC |
| Feb 10, 2020 | Feb 12, 2020 | CL | Grp Pres, Lat Am & Asia Pac | Form 4 sale | 17,702 | $1.4M | 56.9% | Unusual | SEC |
| Feb 7, 2020 | Feb 10, 2020 | CL | Grp Pres, Lat Am & Asia Pac | Form 4 sale | 27,164 | $2.1M | 67.0% | Unusual | SEC |
| Feb 25, 2014 | Feb 27, 2014 | CL | Pres., Colgate-Africa/Eurasia | Form 4 sale | 1,458 | $90k | 3.8% | Plan not stated | SEC |
| Sep 17, 2013 | Sep 19, 2013 | CL | Pres., Colgate-Africa/Eurasia | Form 4 sale | 449 | $27k | 1.3% | Plan not stated | SEC |